Moderate Potency

Moderate Potency

Corticosteroid & Antimicrobial Combination - Mild Potency

Aqueous basis

Chlordiazepoxide is included for its use in acute alcohol withdrawal rather than for use in anxiety.

Chlordiazepoxide is included for its use in acute alcohol withdrawal rather than for use in anxiety.

Licensed oral vitamin B12 formulation for non-dietary related deficiency.

8 mg (4 drops) Cipramil oral drops may be considered to be equivalent in therapeutic effect to 10 mg citalopram tablet.

Low dose Combisal more cost effective than Seretide

Combivent® nebuliser solution should be started only by a Respiratory Physician. It is less expensive to prescribe salbutamol and ipratropium bromide nebuliser solutions separately but this requires patients to nebulise 4.5 mL instead of 2.5 mL.

Enstilar foam is accepted onto the formulary as another formulation of calcipotriol and betamethasone dipropionate for patients with non-scalp psoriasis. The recommended treatment period for foam (and Dovobet ointment) is 4 weeks. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision. General measures such as the frequent use of emollients are important in the management of psoriasis. If using other topical products containing calcipotriol in addition to Enstilar, the total dose of all calcipotriol containing products should not exceed 15 g per day.

Beclometasone diproprionate (Clipper) is an additional option after an oral aminosalicylate in mild to moderate left sided or extensive ulcerative colitis (as per NICE CG for ulcerative colitis). It may be considered for patients in whom the use of prednisolone would best be avoided. GPs need to be aware of the 4 week course and the dosing of 5mg daily for Beclometasone diproprionate and may wish to consider seeking advice from the IBD team when prescribing this steroid.

Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate (Jan 2024 DSU) Please see Cornwall management of infection guidelines for indications.

Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate (Jan 2024 DSU) Please see Cornwall management of infection guidelines for indications.

Very Potent

An alternative to SSRIs in obsessive compulsive disorder

An alternative to SSRIs in obsessive compulsive disorder

An alternative to SSRIs in obsessive compulsive disorder

May only be initiated in primary care for people with type 2 diabetes and no heart failure.

May only be initiated in primary care for people with type 2 diabetes and no heart failure.

For patients who have been diagnosed with head and neck cancer or undertaken a course of radiotherapy, and who require high-strength fluoride toothpaste as part of the cancer pathway, sodium fluoride dental paste sugar-free 1.1% (5000ppm) may be prescribed on a three-monthly basis by their NHS dentist or GP on the advice of the head & neck cancer, maxillofacial, or restorative dental teams. All other prescribing is discouraged.

Cinacalcet is commissioned by NHS England for complex primary hyperparathyroidism in adults and secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. There is a shared care guideline for use in primary hyperparathyroidism

Administered BD

Cinacalcet is commissioned by NHS England for complex primary hyperparathyroidism in adults and secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. There is a shared care guideline for use in primary hyperparathyroidism

Cost-effective alternative to liquid preparations, where tablets cannot be crushed and dissolved. Please note use is off-label for children under 6 years.

If patients have not experienced improvement in their symptoms after 4 weeks of treatment, the patient should be re-examined and the benefit and risks of continuing treatment reconsidered.

Catephen (green tea leaf extract 10% ointment) is accepted onto the formulary as a specialist initiated drug for use in patients not suitable for podophyllotoxin or who have not responded to treatment with podophyllotoxin

Cinacalcet is commissioned by NHS England for complex primary hyperparathyroidism in adults and secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. There is a shared care guideline for use in primary hyperparathyroidism

Very Potent